🇺🇸 Ovid Therapeutics Inc.
Forum topic · OVID · Company page: financials, ownership and filings
Join the discussion on Ovid Therapeutics Inc.
Loading…
Results announced on 10 November 2026
Ovid Therapeutics Inc. announced results on 10 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $21 million.
Mutual funds: 70 funds hold $84 million
70 mutual funds in 1 country hold shares of Ovid Therapeutics Inc. worth $84 million, about 17.3% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 66 funds added shares and 2 sold; on balance they bought $46 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.